155 related articles for article (PubMed ID: 6122514)
21. [Renal effects of intravenous tertatolol in essential arterial hypertension].
Chaignon M; Brouard R; Lucsko M; Guédon J
Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1219-22. PubMed ID: 1979729
[TBL] [Abstract][Full Text] [Related]
22. Beta-blockers and the kidney.
Epstein M; Oster JR
Miner Electrolyte Metab; 1982 Nov; 8(5):237-54. PubMed ID: 6132329
[No Abstract] [Full Text] [Related]
23. Effect of carvedilol on ambulatory blood pressure, renal hemodynamics, and cardiac function in essential hypertension.
Dupont AG; Van der Niepen P; Taeymans Y; Ingels M; Piepsz A; Bossuyt AM; Block P; Six RO; Jonckheer MH; Vanhaelst L
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S130-6. PubMed ID: 2454359
[TBL] [Abstract][Full Text] [Related]
24. Effects of nadolol on systemic and renal hemodynamics in patients with renoparenchymal hypertension and various degrees of renal function.
Valvo E; Gammaro L; Bedogna V; Cavaggioni M; Tonon M; Lupo A; Loschiavo C; Tessitore N; Oldrizzi L; Rugiu G
Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):202-6. PubMed ID: 3710633
[TBL] [Abstract][Full Text] [Related]
25. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
Leenen FH; Davies RA; Fourney A
Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
[TBL] [Abstract][Full Text] [Related]
26. Effect of atenolol, a new cardioselective beta-blocker, on plasma renin activity in treatment of hypertension.
Balansard P; Chabrillat Y; Paulin R; Libes M; Gérard R
Acta Cardiol; 1977; 32(4):229-43. PubMed ID: 304291
[TBL] [Abstract][Full Text] [Related]
27. Systemic and renal hemodynamic effects of celiprolol in essential hypertensives.
Lucarini AR; Salvetti A
Am J Cardiol; 1988 Feb; 61(5):45C-48C. PubMed ID: 2963525
[TBL] [Abstract][Full Text] [Related]
28. Nadolol in essential hypertension: effect on ambulatory blood pressure, renal haemodynamics and cardiac function.
Dupont AG; Vanderniepen P; Bossuyt AM; Jonckheer MH; Six RO
Br J Clin Pharmacol; 1985 Aug; 20(2):93-9. PubMed ID: 2864051
[TBL] [Abstract][Full Text] [Related]
29. The effects of a beta 1-blocking agent, atenolol, on blood pressure, plasma renin activity and prostaglandin F2 alpha excretion in patients with essential hypertension.
Pitkäjärvi T; Ylitalo P; Metsä-Ketelä T; Vapaatalo H
Acta Med Scand; 1979; 206(1-2):107-13. PubMed ID: 484251
[TBL] [Abstract][Full Text] [Related]
30. Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension.
Lund-Johansen P
Br J Clin Pharmacol; 1976 Jun; 3(3):445-51. PubMed ID: 973971
[TBL] [Abstract][Full Text] [Related]
31. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
Sourgens H; Schmidt J; Derendorf H
Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
[TBL] [Abstract][Full Text] [Related]
32. A dose ranging study of atenolol in hypertension: fall in blood pressure and plasma renin activity, beta-blockade and steady-state pharmacokinetics.
Ishizaki T; Oyama Y; Suganuma T; Sasaki T; Nakaya H; Shibuya T; Sato T
Br J Clin Pharmacol; 1983 Jul; 16(1):17-25. PubMed ID: 6349668
[TBL] [Abstract][Full Text] [Related]
33. Atenolol administered once daily in primary hypertension. Effects on blood pressure in relation to pre-treatment plasma renin activity.
Nilsson OR; Karlberg BE; Ohlsson O; Thulin T; Tolagen K
Acta Med Scand; 1979; 206(4):303-8. PubMed ID: 506802
[TBL] [Abstract][Full Text] [Related]
34. Hemodynamic and hormonal adaptations to beta-adrenoceptor blockade. A 24-hour study of acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
van den Meiracker AH; Man in 't Veld AJ; van Eck HJ; Boomsma F; Schalekamp MA
Circulation; 1988 Oct; 78(4):957-68. PubMed ID: 3048776
[TBL] [Abstract][Full Text] [Related]
35. Sympathetic responsiveness and antihypertensive effect of beta-receptor blockade in essential hypertension.
Distler A; Keim HJ; Cordes U; Philipp T; Wolff HP
Am J Med; 1978 Mar; 64(3):446-51. PubMed ID: 25017
[TBL] [Abstract][Full Text] [Related]
36. Comparison of central and peripheral haemodynamic effects of dilevalol and atenolol in essential hypertension.
Tham TC; Silke B; Taylor SH
J Hum Hypertens; 1990 Jun; 4 Suppl 2():77-83. PubMed ID: 2370647
[TBL] [Abstract][Full Text] [Related]
37. Effects of propranolol and atenolol on plasma renin activity and systolic time intervals in borderline hypertension.
González-Gómez A; García-Barreto D; Gamio Capestany F; Hernández-Cañero A; Fong Chi S
Cor Vasa; 1982; 24(6):422-8. PubMed ID: 6764167
[TBL] [Abstract][Full Text] [Related]
38. Renal and cardiac function during alpha1-beta-blockade in congestive heart failure.
Heitmann M; Davidsen U; Stokholm KH; Rasmussen K; Burchardt H; Petersen EB
Scand J Clin Lab Invest; 2002; 62(2):97-104. PubMed ID: 12004934
[TBL] [Abstract][Full Text] [Related]
39. Hemodynamic, reflexive, and metabolic alterations induced by acute and chronic timolol therapy in hypertensive man.
Dunn FG; de Carvalho JG; Frohlich ED
Circulation; 1978 Jan; 57(1):140-4. PubMed ID: 618381
[TBL] [Abstract][Full Text] [Related]
40. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
Lund-Johansen P; Omvik P; Nordrehaug JE; White W
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
